Abstract
Although only 5% of patients with prostate cancer (PCA) have metastases at diagnosis, approximately 20% of those with early stage disease have recurrence with metastases, often years later. Changes in prostate specific antigen (PSA) levels can predict recurrence. A machine learning approach to serum PSA lab kinetics, after diagnosis of localized PCA, was used to forecast progression with metastases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
